Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CeNeRx BioPharma Inc.
DescriptionNon-CNS cannabinoid CB1 receptor antagonist
Molecular Target Cannabinoid CB1 receptor (CNR1)
Mechanism of ActionCannabinoid CB1 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain associated with peripheral neuropathy, glaucoma and spasticity
Regulatory Designation
PartnerNeuroscienze PharmaNess s.c.a r.l.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today